← All trials
NCT04305587
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 16, 2020
- Primary completion
- Nov 19, 2020
- Completion date
- Jan 22, 2021
- First posted
- Mar 12, 2020
- Last posted
- Mar 25, 2020
- Enrollment
- 100
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.